Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

89Bio Inc (NQ: ETNB )

5.145 +0.405 (+8.54%)
Streaming Delayed Price Updated: 3:31 PM EDT, Aug 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 791,599
Open 4.660
Bid (Size) 5.130 (2)
Ask (Size) 5.160 (2)
Prev. Close 4.740
Today's Range 4.558 - 5.580
52wk Range 2.000 - 21.47
Shares Outstanding 39,073,995
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analysts Are Bullish On 89bio's NASH Data Slated For Early Next Year
 
Via Benzinga
89bio Shares Climb After Concluding Enrolment In Mid-Stage NASH Study
89bio (NASDAQ: ETNB) has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of non-alcoholic steatohepatitis (NASH). 
Via Benzinga

Performance

YTD
-65.68%
-65.68%
1 Month
+57.82%
+57.82%
3 Month
+73.82%
+73.82%
6 Month
+2.49%
+2.49%
1 Year
-71.48%
-71.48%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Analyst Ratings for 89bio
Via Benzinga
6 Analysts Have This to Say About 89bio
Via Benzinga
Where 89bio Stands With Analysts
Via Benzinga
Expert Ratings for 89bio
Via Benzinga
This Analyst Thinks 89Bio's Pegozafermin Data Has Exceeded Expectations
Via Benzinga
89bio Posts Promising Pegozafermin Data For Severe Hypertriglyceridemia
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Via Benzinga
Analyst Ratings for 89bio
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Recap: 89bio Q2 Earnings
Via Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Via Benzinga
Disney To $125? Here's The Biggest Price Target Changes For Thursday
Via Benzinga
5 Analysts Have This to Say About 89bio
Via Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
Via Benzinga
U.S. Stock Futures Edge Higher; GDP Report In Focus
Via Benzinga
McCormick, General Mills And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
89bio Pulls Back With Market — But Could The Stock Soar 250%?
Via Benzinga
10 Biggest Price Target Changes For Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
90 Biggest Movers From Yesterday
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
10 Biggest Price Target Changes For Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.